"The Effect of Reiki on Metabolic Parameters in Obese Type 2 Diabetes Patients''
NCT ID: NCT05942079
Last Updated: 2023-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2022-09-15
2023-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the literature, the effects of reiki have been examined in patient groups with different chronic diseases, but no study has been found on obese individuals with Type 2 diabetes. Therefore, reikinin in obese individuals with Type 2 diabetes; This study is planned to determine whether it has an effect on compliance with diabetes treatment, eating behaviors, anxiety levels and changes in metabolic values.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Reiki in Patients With Type-II Diabetes
NCT06617767
New Diagnosed Type 2 Diabetes - Online Education
NCT05341063
Heat Therapy in Patients With Type 2 Diabetes Mellitus
NCT05237219
Type 1 Diabetes,Mindfulness,Yoga,Stress,Health Quality,Glycemic İndex
NCT06202950
Motivational Interviewing in Type 2 Diabetes Patients
NCT05844748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the literature, the effects of reiki have been examined in patient groups with different chronic diseases, but no study has been found on obese individuals with Type 2 diabetes. Therefore, reikinin in obese individuals with Type 2 diabetes; This study is planned to determine whether it has an effect on compliance with diabetes treatment, eating behaviors, anxiety levels and changes in metabolic values.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group receiving reiki
Individuals who will undergo Reiki for 12 weeks
REİKİ
Reiki is applied as an alternative and complementary treatment method.
control group
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
REİKİ
Reiki is applied as an alternative and complementary treatment method.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body mass index ≥ 30 kg/m²
3. Being on oral therapy or using insulin,
4. Ability to communicate and read,
5. Volunteering to participate in research
Exclusion Criteria
2. Answering data collection forms incompletely
3. Desire to leave the study at any stage of the study
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasan Kalyoncu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatmaz zehra KÜÇÜK
PHD STUDENT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harran unv.
Sanliurfa, , Turkey (Türkiye)
Harran Unv
Sanliurfa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fatmaz Zehra KÜÇÜK
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.